June 12, 2017 ALBUQUERQUE, NM and SAN DIEGO, CA –Exagen Diagnostics, Inc., home of AVISE®testing, announced the nationwide availability of a new test leveraging the power of cell-bound complement activation products (CB-CAPs) to help physicians monitor patients with Systemic Lupus Erythematosus (SLE). The AVISE SLE Monitor offering is a unique combination of specialized assaysthat provide valuable insight into SLE disease …

February 16, 2017 07:20 ET ALBUQUERQUE, NM and SAN DIEGO, CA –(Marketwired – February 16, 2017)- Exagen Diagnostics, Inc., home of AVISE® testing, announced today that United Rheumatology LLC., a leading specialist organization in the United States with over 300 physician members, has prominently recommended testing for methotrexate polygluta mate levels in its clinical practice guidelines for adults with rheumatoid …

Contact: Brian McEvilly, Vice President of Marketing – 858.736.5517 SAN DIEGO, CA– A new, non‐invasive blood collection method is now available to help physicians and their patients monitor exposure levels to potentially toxic drugs from a single drop of blood. Unlike other “Micro” or “Nano” sample methods this new approach called AVISE Touch™ has been scientifically validated to demonstrate equivalence …

Contact: Brian McEvilly at: [email protected] SAN DIEGO, CA – Exagen Diagnostics, a rheumatology specialty laboratory with offices in Vista, CA, and Albuquerque, NM, is focused on helping patients and their doctors get speedier and more accurate diagnoses. Today, they produce the only validated lupus test on the market incorporating scientifically proven CB-CAPS technology, and it is having a big impact with both …